Shilpa Medicare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2025
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare has filed the Scrutinizer's Report and voting results of its 38th Annual General Meeting held on September 23, 2025 via video conferencing. All 10 resolutions were passed with the requisite majority, including the adoption of audited financial statements for FY25 and declaration of a dividend of ₹1.00 per equity share. Shareholders approved the re-appointment of Mr. Omprakash Inani (retiring by rotation), Mr. Sharath Reddy Kalakota as Whole Time Director, and Dr. Anita Bandyopadhyay as Women Independent Director. A special resolution was passed for issuing bonus shares, and another for appointing Mr. Ashraf Loutfy Abdelhamid Allam as an Independent Director. Remote e-voting ran from September 19-22, 2025, with a cut-off date of September 17, 2025. Approval levels were very high, with most resolutions receiving over 99% support, though the bonus shares resolution received relatively lower support among those voting (~99.72% in favor) and the secretarial auditor appointment got 98.89%.
Positive for shareholders: the ₹1.00 dividend is confirmed and a bonus share issue has been approved, both of which reward investors. The bonus share proposal in particular could lift retail interest and improve liquidity in the stock. Routine director re-appointments mean continuity in leadership, with limited governance concerns.